NDC 85974-121-41

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC: 85974-121-41
Product root: 85974-121
Identity scope: Package
Primary current NDC product row: Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
compounder	package	85974-121	85974-121-41	COMPOUNDER	Outsourcing facility compounded drug report	2025-1	2026-08-12
compounder	package	85974-121	85974-121-41	COMPOUNDER	Outsourcing facility compounded drug report		2025-09-25

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 1 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Archive	Snapshot	Source SHA-256
2025-12-16 00:49 UTC · source 2025-09-25	compounder	package	85974-121	85974-121-41	COMPOUNDER	Outsourcing facility compounded drug report		compounder / compounders_ndc_directory.zip	`3f6f48d8db7b…`	`6316a3eebc6a…`

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
Establishment	FEI	Product NDC	Package NDC	Product	Active ingredients	Reporting period	Normalization
Bennett Pharmaceuticals of America, LLC	118622266	85974-121	85974-121-41	Tetracaine Hydrochloride; Bupivacaine Hydrochloride; Phenylephrine Hydrochloride	40 mg/1 mL; 5 mg/1 mL; 10 mg/1 mL	2025-1	valid
Bennett Pharmaceuticals of America, LLC		85974-121	85974-121-41	tetracaine hcl 4%, bupivacaine hcl 0.5%, phenylephrine 1% liquid	TETRACAINE HYDROCHLORIDE; BUPIVACAINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE		source_anomaly